-
-
-
-
-
-
-
-
-
-
-
Risk factors for red blood cell alloimmunization in patients with hematologic malignancy Transfus. Med. (IF 1.5) Pub Date : 2024-09-12 Pakthipa Pattarakosol, Nattarat Lorucharoen, Phandee Watanaboonyongcharoen, Ponlapat Rojnuckarin
IntroductionPatients with hematologic malignancy have a higher risk of developing red blood cell (RBC) alloimmunization which can delay blood transfusion. Information on the risk factors for alloimmunization in this group is still limited. This study aimed to determine the prevalence and predictors of RBC alloimmunization among these patients.Materials and MethodsElectronic medical records of the patients
-
Implementation challenges of electronic blood transfusion safety systems: Lessons from an international, multi‐site comparative case study Transfus. Med. (IF 1.5) Pub Date : 2024-09-10 Stijn Horck, Nick Fahy, Trisha Greenhalgh
BackgroundSevere transfusion reactions resulting from errors in matching the correct blood with the correct patient are considered never events. Despite the relative technical simplicity of barcode scanning for patient‐blood bag matching, the adoption and universal application of this safety measure are by no means universal. This study highlights the logistical and institutional challenges associated
-
Characterising practice patterns of human derived, lyophilized coagulation concentrates within the trauma quality improvement program registry Transfus. Med. (IF 1.5) Pub Date : 2024-09-10 Chester A. Rosenthal, David J. Douin, Mitch J. Cohen, Julie A. Rizzo, Michael D. April, Steven G. Schauer
ObjectivesWe seek to describe the current practice pattern use of prothrombin complex concentrate (PCC) and fibrinogen concentrate (FC) in trauma patients.BackgroundTrauma‐induced coagulopathy (TIC) and endotheliopathy of trauma (EOT) contribute significantly to mortality from traumatic haemorrhage. FC, and 4‐factor PCC are potential treatments for EOT and TIC, respectively.Materials and MethodsWe
-
An evaluation of diethylhexyl phthalate free top & bottom in‐line blood collection set with a new soft housing filter Transfus. Med. (IF 1.5) Pub Date : 2024-09-07 Elena Danilova, Farshid Ezligini, Connie Stöckel, Masafumi Asakawa, Geir Hetland
Background and ObjectivesDi (2‐ethylhexyl) phthalate (DEHP) plasticizer must be removed from polyvinylchloride (PVC) medical devices due to toxicity. DEHP/PVC blood bags were shown to provide stable quality under blood component production and to create good storage conditions for red blood cells concentrate (RBC). It is important that substitution of the DEHP maintains the RBC quality during storage
-
Transfusion sample mislabelling and wrong blood in tube in the UK: Insights from the national comparative audits of blood transfusion in 2012 and 2022 Transfus. Med. (IF 1.5) Pub Date : 2024-08-28 Catherine Booth, Paul Davies
BackgroundSamples for transfusion rejected due to mislabelling can lead to harm when a patient has to be re‐bled or has a transfusion or procedure delayed. Electronic labelling systems which scan the patient's identification band and generate a label at their side aim to reduce mislabelling and misidentification leading to wrong blood in tube (WBIT) errors. The 2022 National Comparative audit of sample
-
Myoglobin saturation as an intracellular indicator for transfusion need in oncology patients Transfus. Med. (IF 1.5) Pub Date : 2024-08-28 Kenneth A. Schenkman, Wayne A. Ciesielski, Terry B. Gernsheimer, Lorilee S. L. Arakaki
ObjectivesThis study aims to demonstrate the potential of myoglobin saturation as an indicator of oxygen delivery adequacy to help determine the need for red cell transfusion.BackgroundModern blood management approaches have been established to optimise use of red blood cells for transfusions in patients with anaemia. However, most approaches make recommendations to transfuse based on haemoglobin or
-
Construction of a decision model for donor testing in cases of suspected antibody‐mediated transfusion‐related‐acute‐lung‐injury Transfus. Med. (IF 1.5) Pub Date : 2024-08-26 Tom Latham, Andrew Bentley, Sharran Grey, Puneet Malhotra, Peter J. Davis, Jill Clarkson, Anthony Poles, Shruthi Narayan
ObjectiveTo propose a rational basis for donor testing in cases of suspected antibody‐mediated transfusion‐related lung injury (AMT).BackgroundAnti‐leukocyte antibodies in donated blood are established causes of transfusion‐related lung injury (TRALI). However, the question of whether to test donors for antibodies is not identical to whether the case meets definition criteria for TRALI. There is a
-
Evaluating utility of routine ferritin testing in blood donors: A hospital‐based blood donor centre experience Transfus. Med. (IF 1.5) Pub Date : 2024-08-26 Philip Petersen, Hesamedin Hakimjavadi, Srikar Chamala, Gagan Mathur
Background and ObjectivesIron deficiency (ID) poses a prevalent concern among blood donors, especially impacting young donors, premenopausal females and frequent donors. In alignment with recommendations to address ID, routine ferritin testing was implemented in a hospital‐based donor centre.Materials and MethodsData set, encompassing 26 164 ferritin values from 16 464 blood donors over 33 months,
-
CEBPA and GATA2 mutation and a transient blood group discrepancy in a patient with acute myeloid leukaemia Transfus. Med. (IF 1.5) Pub Date : 2024-08-26 Marie Solange Flores‐Morán, Enric Fuste
-
Identification of two novel RHD and one novel RHCE gene promoter variants in Chinese Han blood donors Transfus. Med. (IF 1.5) Pub Date : 2024-08-19 Lin‐Nan Shao, Shu‐Ting Zhang, Nan Xiao, Ying Duan, Shi‐Hang Zhou
-
Establishment and discussion of autoverification rules for transfusion compatibility testing Transfus. Med. (IF 1.5) Pub Date : 2024-08-11 Daobo Peng, Xiaohui Wang, Jie Huang
ObjectivesTo develop an automated verification workflow for transfusion compatibility testing (TCT) based on the AUTO10‐A guidelines and blood group serology characteristics and to conduct a simulated validation of the test and subtest results by assessing the appropriateness of the autoverification rules.BackgroundThe accuracy of TCT results is a fundamental prerequisite for ensuring the safety of
-
Transfusion Camp: The UK experience and its value in improving knowledge of transfusion medicine among postgraduate trainees Transfus. Med. (IF 1.5) Pub Date : 2024-08-09 Asha Aggarwal, Kunaal Kaushik, Suzy Morton, Anicee Danaee, Kamala Gurung, Susan Robinson, Casey Kapitany, Sophie Charge, Yulia Lin, Mike Desborough, Michael F. Murphy
ObjectivesTo report the UK experience of rolling out Transfusion Camp.BackgroundTransfusion Camp is a structured education programme developed in Toronto, with the aim of reducing knowledge gaps in transfusion medicine in postgraduate trainees. It consists of didactic lectures viewed online by the participants, then interactive, locally delivered seminars. Since 2015, it has been rolled out in the
-
-
Stability of immunohaematological reagents used for blood typing of recipients in the tube technique Transfus. Med. (IF 1.5) Pub Date : 2024-08-09 Julia Hermes, Mariane Stefanes Carloto, Amanda Leal, Flávia Martinello
Background and ObjectivesThe storage temperature of immunohaematological reagents generally ranges from 2 to 8°C, and they should be utilised at room temperature. This study aimed to analyse the stability of immunohaematological reagents used in ABO and RhD typing.MethodsThe evaluation encompassed the potency, specificity, and integrity of anti‐A, anti‐B, anti‐D, RhD control sera, and A1 and B red
-
The use of predictive modelling to determine the likelihood of donor return during the COVID‐19 pandemic Transfus. Med. (IF 1.5) Pub Date : 2024-08-08 Richard R. Gammon, Salwa Hindawi, Arwa Z. Al‐Riyami, Ai Leen Ang, Renee Bazin, Evan M. Bloch, Kelley Counts, Vincenzo de Angelis, Ruchika Goel, Rada M. Grubovic Rastvorceva, Ilaria Pati, Cheuk‐Kwong Lee, Massimo La Raja, Carlo Mengoli, Adaeze Oreh, Gopal Kumar Patidar, Naomi Rahimi‐Levene, Usharee Ravula, Karl Rexer, Cynthia So‐Osman, Jecko Thachil, Michel Toungouz Nevessignsky, Marion Vermeulen
Artificial intelligence (AI) uses sophisticated algorithms to “learn” from large volumes of data. This could be used to optimise recruitment of blood donors through predictive modelling of future blood supply, based on previous donation and transfusion demand. We sought to assess utilisation of predictive modelling and AI blood establishments (BE) and conducted predictive modelling to illustrate its
-
Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako Transfus. Med. (IF 1.5) Pub Date : 2024-08-06 Minkoro Fomba, Boubacari Toure, Cécile Toly N'dour, Aliou Bagayoko, Mounirou Baby
Background and ObjectivesPregnancy in women with sickle cell disease (SCD) is associated with severe complications. Red blood cell (RBC) alloimmunisation is a worrying situation in pregnant women with SCD. This could increase the difficulty in finding a pheno‐compatible red blood product. Our study aimed to determine the prevalence of RBC alloantibodies in pregnant women with SCD and to determine the
-
Identification of a novel RHCE*Ce (829G > A) allele associated with absence of C and e antigens expression Transfus. Med. (IF 1.5) Pub Date : 2024-08-01 Ci Xuan, Fan Xinxin, Lv Piao, Kong Wenbin, Liang Yingyin, Liu Chixiang, Zhou Huayou
BackgroundThe Rh blood group antigens are encoded by the RHD and RHCE genes, which possess a remarkable degree of polymorphism owing to their high homologous structures. These variants of the RH genes can lead to absence or weak expression of antigens.MethodsAnalysis of RHCE genotyping by Polymerase Chain Reaction (PCR‐SSP) method specific to detect c.48G, c.48C, 109 bp insertion of IVS2, c.201A and
-
A rapid review of motives and barriers for living substance of human origin donation and an extended typology Transfus. Med. (IF 1.5) Pub Date : 2024-07-24 Melissa K. Hyde, Meenu Kumarasinghe, Barbara M. Masser
Our objective is to review motives and barriers for non‐reproductive, living substance of human origin (SoHO) donation, and to extend existing typologies beyond blood. The expansion of SoHO collection is currently unmatched by increased living donors. Thus, there is a critical need to understand how to effectively recruit and retain donors to ensure a sustainable supply of SoHO. We undertook a rapid
-
Analysis of the effect and influencing factors of a clinical competency‐oriented prospective pre‐job training programme on the comprehensive ability of new employees in the department of transfusion medicine Transfus. Med. (IF 1.5) Pub Date : 2024-07-24 Fu Cheng, Yingying Niu, Bing Han, Chunxia Chen, Huan Yang, Jiaheng Li, Dongmei Yang, Bin Tan
BackgroundThe subject of pre‐job training for transfusion service laboratory technicians is very important. The key is how to make a reasonable systematic training programme to improve the effectiveness of training.MethodsA prospective training programme was conducted and an assessment was performed at enrollment (baseline) and reassessment after 3‐months training, using the same tools with a validated
-
Determining the strength of evidence for an association between sexual indicators and risk of acquiring HIV and sexulaly transmitted infections: Providing evidence for blood donation policy change Transfus. Med. (IF 1.5) Pub Date : 2024-07-23 Joe Flannagan, Katy L. Davison, Claire Reynolds, Susan R. Brailsford
In 2019 the For The Assessment Of Individualised Risk (FAIR) project began a review of UK blood donor selection policy to determine if a more individualised approach to donor selection could be safely implemented. An evidence base was required to inform selection policy to move from a population to a more individual based policy, specifically what sexual behaviours/indicators should be considered as
-
Allogenic and autologous nondiluted serum eye drops—validation strategy compliant with good manufacturing practice Transfus. Med. (IF 1.5) Pub Date : 2024-07-22 Frauke Dormann, Viola Hähnel, Viktoria Müller, Ralph Burkhardt, Robert Offner
Background and aimsSerum eye drops alleviate ocular symptoms of diseases such as sicca syndrome, or chronic graft‐versus‐host disease. This study was designed for good manufacturing practice validation of our standard manufacturing, storage and transport processes for both autologous and allogenic SEDs. Specifications of quality parameters are lacking and were aimed to be defined.MethodsUsing sterile
-
Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study Transfus. Med. (IF 1.5) Pub Date : 2024-07-20 Shipra Taneja, Nancy M. Heddle, Christopher Hillis, Shannon Lane, Meera Karunakaran, Dawn Maze, Dimpy Modi, Dina Khalaf, Donald M. Arnold, Hassan Zahreddine, Kathryn Webert, Laura Hess, Richard Cook, Simon Stanworth, Terry Gernsheimer, Meredith Vanstone
BackgroundBleeding is a primary outcome for many transfusion‐related trials in acute leukaemia (AL) patients, typically graded using the World Health Organisation (WHO) bleeding scale (clinically significant bleed (CSB) is ≥grade 2). This composite outcome fails to differentiate minor bleeds that may not be significant, poorly represents the total burden of bleeding and lacks input from healthcare
-
Genetic variation of FUT3 gene in the Han population from Northern China Transfus. Med. (IF 1.5) Pub Date : 2024-07-19 Shihang Zhou, Ziwei Zheng, Liying Wang, Wenqian Song, Yuexin Xia, Linnan Shao, Xiaohua Liang
Background and ObjectivesThe FUT3 gene encodes α(1,3/1,4)‐fucosyltransferase, which is a crucial enzyme in the synthesis of Lewis antigens. FUT3 gene variants show race‐specific differences. In this study, we conducted a systematic sequence analysis of the FUT3 coding sequence. The objective was to explore genetic variations of the FUT3 gene within the Han population of Northern China.Materials and
-
Preventing misinterpretation of rare blood types in clinical laboratories: A case study on B3 phenotype Transfus. Med. (IF 1.5) Pub Date : 2024-07-17 Ying‐Ju Chen, Yung‐Che Chou, Tze‐Kiong Er
-
-
Impact of introduction of a goal directed transfusion strategy in a patient blood management program: A single cardiac surgery centre experience Transfus. Med. (IF 1.5) Pub Date : 2024-07-01 Riccardo Fiameni, Matteo Lucchelli, Chiara Novelli, Valentina Salice, Francesca Orsenigo, Mattia Gomarasca, Bedrana MoroSalihovic, Federico Mondin, Giovanni Mistraletti, Ivo Beverina
BackgroundThe aim of this retrospective and observational study was to analyse the impact of the introduction of a goal directed transfusion (GDT) strategy based on a viscoelastic test (ROTEM®) and specific procoagulant products in a patient blood management (PBM) Program on blood product use and perioperative bleeding in a single cardiac surgery centre.Study Design and MethodsPatient population underwent
-
Evaluation of platelet concentrates prepared using different methods after overnight holding (18–24 h) of whole blood at room temperature Transfus. Med. (IF 1.5) Pub Date : 2024-06-30 Deviprasanna Mohanty, Rahul Chaurasia, Anand Kumar, Gopal Kumar Patidar, Hem Chandra Pandey, Arulselvi Subramanian
Background and ObjectivesRegulatory requirement of fixed holding time (6 h) of whole blood (WB) at room temperature, that is, 22–24°C (RT) results in sub‐optimal component separation. The aim was to evaluate the platelet concentrates (PC) prepared by both platelet rich plasma (PRP) and buffy coat (BC) methods after overnight hold (18–24 h) at RT.Materials and MethodsA prospective experimental study
-
A review of immunoglobulin use in a district general hospital setting Transfus. Med. (IF 1.5) Pub Date : 2024-06-26 Julie Gillies, Lorna Robertson, Debbie Tait
-
Every minute counts: A comparison of thawing times and haemostatic quality of plasma thawed at 37°C and 45°C using four different methods Transfus. Med. (IF 1.5) Pub Date : 2024-06-23 J. McCullagh, C. Booth, J. Lancut, S. Platton, P. Richards, L. Green
BackgroundHaving faster plasma thawing devices could be beneficial for transfusion services, as it may improve the rapid availability of thawed plasma for bleeding patients, and it might remove the need to have extended pre‐thawed plasma: thus, reducing unnecessary plasma wastage.Study Design and MethodsThe aims of this study were to assess (a) the thawing times and (b) in vitro haemostatic quality
-
A rapid review of strategies to manage low iron levels in adults donating whole‐blood: A focus on donor behaviour Transfus. Med. (IF 1.5) Pub Date : 2024-06-21 Amanda Thijsen, Carley N. Gemelli, Melissa K. Hyde, Rachel Thorpe, Barbara M. Masser
In recognition of the impact of whole‐blood donation on body iron stores, there has been an increased focus assessing the efficacy of strategies to minimise the risk of iron deficiency (ID). Whilst donor behaviour is an important determinant of success, this literature is yet to be fully synthesised to help guide blood collection agencies when implementing these strategies into routine practice. This
-
Perioperative transfusion study (PETS): Does a liberal transfusion protocol improve outcome in high-risk cardiovascular patients undergoing non-cardiac surgery? A randomised controlled pilot study. Transfus. Med. (IF 1.5) Pub Date : 2024-06-18 Samir Ali,Steven Roubos,Sanne E Hoeks,Serge J C Verbrugge,Ankie W M M Koopman-van Gemert,Robert Jan Stolker,Felix van Lier
BACKGROUND Small studies have shown that patients with advanced coronary artery disease might benefit from a more liberal blood transfusion strategy. The goal of this pilot study was to test the feasibility of a blood transfusion intervention in a group of vascular surgery patients who have elevated cardiac troponins in rest. METHODS We conducted a single-centre, randomised controlled pilot study.
-
'Old is gold' does conventional test tube method still reign supreme? An immuno-haematological survey of anti-D detection and titration in ante-natal cases among major hospitals across India. Transfus. Med. (IF 1.5) Pub Date : 2024-06-18 Prashant Pandey,Arghyadeep Marik,Aseem Tiwari,Sudipta Shekhar Das,Shamee Shastry,Mohit Chowdhry,Supriya Kumari
INTRODUCTION Anti-D detection and titration plays a major role in RhD negative antenatal cases both, for monitoring maternal as well as fetal status as well as initiation of early therapeutic interventions, such as intra-uterine transfusions (IUT) to improve maternal as well as fetal morbidity and mortality and reduce the adverse effects of haemolytic disease of fetus and newborn (HDFN). We conducted
-
Accuracy of RHC/c genotyping in Chinese Han population Transfus. Med. (IF 1.5) Pub Date : 2024-05-29 Shihang Zhou, Ming Liu, Linnan Shao, Wenqian Song, Liying Wang, Yaxin Fan
Background and ObjectivesThe RHCE gene plays an important role in the complex and polymorphic Rh blood group system. RHCE genotyping holds significant clinical and transfusion‐related implications. The objective of this study was to evaluate the accuracy of RHC/c genotyping in the Chinese Han population.Materials and MethodsBlood samples were obtained from 653 Chinese Han blood donors. The serological
-
Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation Transfus. Med. (IF 1.5) Pub Date : 2024-05-28 Piyapong Simtong, Amonrat Jumnainsong, Chanvit Leelayuwat
BackgroundAntibodies against blood group antigens play a key role in the pathophysiology of haemolytic transfusion reactions (HTRs) and haemolytic disease of the fetus and newborn (HDFN). This study aimed to determine the frequencies of alleles, genotypes, and risk of alloimmunisation of clinically significant blood group systems in ethnic northeastern Thais.MethodsIn total, 345 unrelated, healthy
-
BNT162b2 mRNA vaccine in transfusion dependent thalassemia patients Transfus. Med. (IF 1.5) Pub Date : 2024-05-25 Hinpetch Daungsupawong, Viroj Wiwanitkit
-
Amber coloured plasma—Case for illustration Transfus. Med. (IF 1.5) Pub Date : 2024-05-14 Amita Radhakrishnan Nair, Baby Saritha Gopalakrishnan, Debasish Gupta
IntroductionAbnormal colour of plasma is infrequently identified during processing of blood and blood components. Common reasons include haemolysis, medications or diet related. Sometimes, the aetiology is unknown. It is a dilemma for every transfusion specialist encountering this situation. Effort should be made to find the aetiology of discolouration of plasma, so that the blood donor can be suitably
-
Rhnull phenotype in an Indian patient due to a novel c.1138 + 2 t > a mutation in the RHAG gene Transfus. Med. (IF 1.5) Pub Date : 2024-05-07 Soumee Banerjee, Ankit Mathur, Neha Hurkat, Santanu Chakraborty, T. V. Reddy
BackgroundThe Rh system is an extremely important RBC antigen system with over 50 antigens, 5 of which (D, C, E, c and e) are considered most clinically significant. The rare Rhnull phenotype can result from mutations in the RHD and RHCE genes or the RHAG gene that affects their expression. This is a case report of the second type.Case ReportThis case reports a multiparous lady who had to be evaluated
-
Lipidomic changes occurring in platelets during extended cold storage Transfus. Med. (IF 1.5) Pub Date : 2024-04-29 Sarah M. Green, Matthew P. Padula, Tyren M. Dodgen, Amani Batarseh, Denese C. Marks, Lacey Johnson
ObjectivesCold storage is being implemented as an alternative to conventional room‐temperature storage for extending the shelf‐life of platelet components beyond 5–7 days. The aim of this study was to characterise the lipid profile of platelets stored under standard room‐temperature or cold (refrigerated) conditions.MethodsMatched apheresis derived platelet components in 60% PAS‐E/40% plasma (n = 8)
-
Cost analysis of care and blood transfusions in patients with Major Obstetric Haemorrhage in Ireland Transfus. Med. (IF 1.5) Pub Date : 2024-04-26 Ahmed Lutfi, Brendan McElroy, Richard A. Greene, John R. Higgins
Background and ObjectivesObstetric haemorrhage is the leading cause of maternal morbidity and mortality worldwide. We aimed to estimate the economic cost of Major Obstetric Haemorrhage (MOH) and the cost of therapeutic blood components used in the management of MOH in Ireland.Materials and MethodsWe performed a nationwide cross‐sectional study utilising top‐down and bottom‐up costing methods on women
-
Frequency of red blood cell phenotypes from genotyped Australian blood donors Transfus. Med. (IF 1.5) Pub Date : 2024-04-25 Georgina Jacko, Tanya Powley, James Daly
BackgroundAustralian Red Cross Lifeblood (Lifeblood) performs human erythrocyte antigen (HEA) genotyping for a subset of repeat whole‐blood donors through preferential selection which aims to maximise variation of results and possibility of identifying donors lacking high frequency red cell antigens.Materials and MethodsThe HEA Molecular Bead chip™ assay is used by Lifeblood for donor genotyping. A
-
Use of automated haematology analysers for the quality control of blood components for transfusion: Comment on Valina et al. (Transfusion Medicine 2024;34:30–38) Transfus. Med. (IF 1.5) Pub Date : 2024-04-23 Albert Farrugia
-
Surgical patients' perception about risks related to blood transfusion: A cross‐sectional survey Transfus. Med. (IF 1.5) Pub Date : 2024-04-22 Kapeel Dev, Aliya Ahmed
ObjectiveTo determine the perception of surgical patients at Aga Khan University Hospital (AKUH) about the risks related to blood transfusion. The ultimate aim was to influence patients' acceptability of blood transfusion by reducing their fears through effective counselling.BackgroundAKUH has a hospital‐based blood bank with more than 90% family replacement donation. Many patients perceive blood transfusion
-
Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients Transfus. Med. (IF 1.5) Pub Date : 2024-04-18 M. Marziali, P. Pugliese, A. A. Losardo, M. Ribersani, E. Anastasi, A. Angeloni, A. Pavan, G. Gentile
-
Transfusion Evidence Synopsis: Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial) Transfus. Med. (IF 1.5) Pub Date : 2024-04-18 Asha Aggarwal
Clinical question: In haematology and intensive care (ICU) patients with a platelet count of 10–50 × 109/L, does withholding platelet transfusion prior to central venous catheter (CVC) insertion increase the incidence of bleeding in comparison to transfusing one unit of platelets? Evidence from study: Withholding platelet transfusion did not meet the criteria for non-inferiority and resulted in more
-
-
-
The feasibility of introducing a whole blood component for traumatic haemorrhage in the UK Transfus. Med. (IF 1.5) Pub Date : 2024-04-05 Josephine McCullagh, Peter Basham, Jane Davies, Vicky Hicks, Alastair Hunter, Julia Lancut, Laura Green
BackgroundThe interest in re‐introducing whole blood (WB) transfusion for the management of traumatic major haemorrhage is increasing. However, due to the current leucodepletion filters used in the UK a WB component was not readily available. Instead, an alternative but similar component, leucocyte depleted red cell and plasma (LD‐RCP), which provided a unique experience in assessing the feasibility
-
Reactivity of anti‐SARS‐CoV‐2 antibodies in Serbian voluntary blood donors Transfus. Med. (IF 1.5) Pub Date : 2024-04-02 Milomir Radoslav Bezanovic, Zorana Budakov Obradovic, Nevenka Bujandric, Neda Kocic, Mirjana Krga Milanovic, Milan Majkic, Boris Obrovski, Jasmina Grujic
BackgroundThe COVID‐19 pandemic has major implications on the entire blood supply system worldwide. Seroepidemiological studies are certainly necessary for better understanding the global burden that the COVID‐19 pandemic represents.ObjectivesIn this study, we analysed the association between demographic factors, COVID‐19 severity, vaccination status and the reactivity of anti‐SARS‐CoV‐2 IgG antibodies
-
Optimizing blood utilization: Experience of blood redistribution policy from a tertiary care hospital based blood centre Transfus. Med. (IF 1.5) Pub Date : 2024-03-27 Gopal K. Patidar, Vidushi Gupta, Anjali Hazarika
-
Charles Waller and Edward Doubleday—Colleagues of James Blundell and early supporters of blood transfusion Transfus. Med. (IF 1.5) Pub Date : 2024-03-22 Phil Learoyd
The obstetrician James Blundell performed the first human‐to‐human blood transfusion in England during the early part of the 19th century arguing that it could be used as a treatment for post‐partum haemorrhage. During this period, Blundell personally acknowledged two of his medical colleagues Charles Waller and Edward Doubleday as being strong supporters of the use of blood transfusion. This paper